服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-PCSK9 mAbs [Recaticimab Biosimilar] (MABL-5147) | MABL-5147 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL1RL2/IL1Rrp2/IL1RRP2/IL-36R/IL36R mAbs [Recibokibart Biosimilar] (MABL-5148) | MABL-5148 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SIGLEC4/MAG mAbs [Refanezumab Biosimilar] (MABL-5149) | MABL-5149 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGFB mAbs [Reflocibart Biosimilar] (MABL-5150) | MABL-5150 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Regdanvimab Biosimilar] (MABL-5151) | MABL-5151 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-LAG3/CD223 mAbs [Relatlimab Biosimilar] (MABL-5152) | MABL-5152 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-NGFB mAbs [Relfovetmab Biosimilar] (MABL-5153) | MABL-5153 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-APP mAbs [Remternetug Biosimilar] (MABL-5154) | MABL-5154 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL17A;TNF/TNFA mAbs [Remtolumab Biosimilar] (MABL-5155) | MABL-5155 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-VTCN1/B7H4 mAbs [Puxitatug Biosimilar] (MABL-5125) | MABL-5125 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CTLA4/CD152 mAbs [Quavonlimab Biosimilar] (MABL-5126) | MABL-5126 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CX3CL1 mAbs [Quetmolimab Biosimilar] (MABL-5127) | MABL-5127 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-IGHE mAbs [Quilizumab Biosimilar] (MABL-5128) | MABL-5128 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFSF14/CD258 mAbs [Quisovalimab Biosimilar] (MABL-5129) | MABL-5129 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Idiotope of anti-NeuGc-ganliosides mAbs [Racotumomab Biosimilar] (MABL-5130) | MABL-5130 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL4R/CD124 mAbs [Rademikibart Biosimilar] (MABL-5131) | MABL-5131 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-FN extracellular domain B mAbs [Radretumab Biosimilar] (MABL-5132) | MABL-5132 | ELISA, FACS, Functional assay, in vivo binding | E, Kappa |
| Anti-Rabies Virus Antigenic Site III mAbs [Rafivirumab Biosimilar] (MABL-5133) | MABL-5133 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-TNFRSF18/CD357/GITR mAbs [Ragifilimab Biosimilar] (MABL-5134) | MABL-5134 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB mAbs [Ragistomig Biosimilar] (MABL-5135) | MABL-5135 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Lambda |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn